Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Medial temporal N-acetyl-aspartate in pediatric major depression.

MacMaster FP, Moore GJ, Russell A, Mirza Y, Taormina SP, Buhagiar C, Rosenberg DR.

Psychiatry Res. 2008 Oct 30;164(1):86-9. doi: 10.1016/j.pscychresns.2007.12.022. Epub 2008 Aug 13.

2.

Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder.

Fitzgerald KD, Moore GJ, Paulson LA, Stewart CM, Rosenberg DR.

Biol Psychiatry. 2000 Feb 1;47(3):174-82.

PMID:
10682215
3.

Left medial temporal cytosolic choline in early onset depression.

Kusumakar V, MacMaster FP, Gates L, Sparkes SJ, Khan SC.

Can J Psychiatry. 2001 Dec;46(10):959-64.

PMID:
11816318
4.

Progressive decrease of N-acetylaspartate to total creatine ratio in the pregenual anterior cingulate cortex in patients with major depressive disorder: longitudinal 1H-MR spectroscopy study.

Tae WS, Kim SS, Lee KU, Nam EC, Koh SH.

Acta Radiol. 2014 Jun;55(5):594-603. doi: 10.1177/0284185113502744. Epub 2013 Sep 12.

PMID:
24031048
5.

Reduced medial prefrontal N-acetyl-aspartate levels in pediatric major depressive disorder: a multi-voxel in vivo(1)H spectroscopy study.

Olvera RL, Caetano SC, Stanley JA, Chen HH, Nicoletti M, Hatch JP, Fonseca M, Pliszka SR, Soares JC.

Psychiatry Res. 2010 Nov 30;184(2):71-6. doi: 10.1016/j.pscychresns.2010.07.008.

6.

Similarities of biochemical abnormalities between major depressive disorder and bipolar depression: a proton magnetic resonance spectroscopy study.

Zhong S, Wang Y, Zhao G, Xiang Q, Ling X, Liu S, Huang L, Jia Y.

J Affect Disord. 2014 Oct;168:380-6. doi: 10.1016/j.jad.2014.07.024. Epub 2014 Jul 24.

PMID:
25106035
7.

Lateralized caudate metabolic abnormalities in adolescent major depressive disorder: a proton MR spectroscopy study.

Gabbay V, Hess DA, Liu S, Babb JS, Klein RG, Gonen O.

Am J Psychiatry. 2007 Dec;164(12):1881-9.

8.

Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls.

Rosenberg DR, Mirza Y, Russell A, Tang J, Smith JM, Banerjee SP, Bhandari R, Rose M, Ivey J, Boyd C, Moore GJ.

J Am Acad Child Adolesc Psychiatry. 2004 Sep;43(9):1146-53.

PMID:
15322418
9.

A pilot study of hippocampal N-acetyl-aspartate in youth with treatment resistant major depression.

Lefebvre D, Langevin LM, Jaworska N, Harris AD, Lebel RM, Jasaui Y, Kirton A, Wilkes TC, Sembo M, Swansburg R, MacMaster FP.

J Affect Disord. 2017 Jan 1;207:110-113. doi: 10.1016/j.jad.2016.05.077. Epub 2016 Oct 1.

PMID:
27721183
10.

Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imaging.

Rosenberg DR, Amponsah A, Sullivan A, MacMillan S, Moore GJ.

J Child Neurol. 2001 Sep;16(9):636-41.

PMID:
11575601
11.

Biochemical abnormalities of the medial temporal lobe and medial prefrontal cortex in late-life depression.

Venkatraman TN, Krishnan RR, Steffens DC, Song AW, Taylor WD.

Psychiatry Res. 2009 Apr 30;172(1):49-54. doi: 10.1016/j.pscychresns.2008.07.001.

12.

Antidepressant effect detected on proton magnetic resonance spectroscopy in drug-naïve female patients with first-episode major depression.

Kaymak SU, Demir B, Oğuz KK, Sentürk S, Uluğ B.

Psychiatry Clin Neurosci. 2009 Jun;63(3):350-6. doi: 10.1111/j.1440-1819.2009.01951.x.

13.

Anterior cingulate cortex and cerebellar hemisphere neurometabolite changes in depression treatment: A 1H magnetic resonance spectroscopy study.

Chen LP, Dai HY, Dai ZZ, Xu CT, Wu RH.

Psychiatry Clin Neurosci. 2014 May;68(5):357-64. doi: 10.1111/pcn.12138. Epub 2014 Jan 7.

14.

Proton magnetic resonance spectroscopy of brain in congenital myotonic dystrophy.

Hashimoto T, Tayama M, Yoshimoto T, Miyazaki M, Harada M, Miyoshi H, Tanouchi M, Kuroda Y.

Pediatr Neurol. 1995 May;12(4):335-40.

PMID:
7546006
15.

Proton MR spectroscopy in patients with neurofibromatosis type 1: evaluation of hamartomas and clinical correlation.

Castillo M, Green C, Kwock L, Smith K, Wilson D, Schiro S, Greenwood R.

AJNR Am J Neuroradiol. 1995 Jan;16(1):141-7. Erratum in: AJNR Am J Neuroradiol 1995 Apr;16(4):808.

16.

Frontal white matter biochemical abnormalities in first-episode, treatment-naive patients with major depressive disorder: a proton magnetic resonance spectroscopy study.

Wang Y, Jia Y, Xu G, Ling X, Liu S, Huang L.

J Affect Disord. 2012 Feb;136(3):620-6. doi: 10.1016/j.jad.2011.10.020. Epub 2011 Nov 29.

PMID:
22129769
17.

The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients.

Gonul AS, Kitis O, Ozan E, Akdeniz F, Eker C, Eker OD, Vahip S.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jan;30(1):120-5. Epub 2005 Oct 19.

PMID:
16236417
18.

Decreased prefrontal Myo-inositol in major depressive disorder.

Coupland NJ, Ogilvie CJ, Hegadoren KM, Seres P, Hanstock CC, Allen PS.

Biol Psychiatry. 2005 Jun 15;57(12):1526-34.

PMID:
15953489
19.

Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study.

Smith EA, Russell A, Lorch E, Banerjee SP, Rose M, Ivey J, Bhandari R, Moore GJ, Rosenberg DR.

Biol Psychiatry. 2003 Dec 15;54(12):1399-405.

PMID:
14675804
20.

Hippocampal N-acetylaspartate and morning cortisol levels in drug-naive, first-episode patients with major depressive disorder: effects of treatment.

Wang Y, Jia Y, Chen X, Ling X, Liu S, Xu G, Huang L.

J Psychopharmacol. 2012 Nov;26(11):1463-70. doi: 10.1177/0269881112450781. Epub 2012 Jun 15.

PMID:
22706518

Supplemental Content

Support Center